Search Within

Andreas Georg Wibmer

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (3)
Groups
  1. Epidemiology and Biostatistics (22)
  2. Sloan Kettering Institute Postdocs (22)
  3. Biostatistics Service (19)
  4. GSK Faculty (16)
  5. Radiology, Department of (14)
  6. Center for Molecular Imaging and Biotechnology (13)

More Groups

People
  1. Hebert Vargas Alvarez (13)
  2. Hedvig Hricak (12)
  3. Junting Zheng (10)
  4. Howard Scher (8)
  5. Michael Morris (7)
  6. Chaya Moskowitz (5)

More People

Years
  1. 2023 (3)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (1)
  6. 2017 (1)

More Years

Publications
  1. American Journal of Roentgenology (5)
  2. Radiology (3)
  3. Clinical Cancer Research (2)
  4. Journal of Clinical Oncology (2)
  5. Abdominal Radiology (1)
  6. Clinical Genitourinary Cancer (1)

More Publications

Publishers
  1. American Roentgen Ray Society (5)
  2. American Society of Clinical Oncology (3)
  3. Radiological Society of North America, Inc. (3)
  4. American Association for Cancer Research (2)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • Local failure after prostate SBRT predominantly occurs in the PI-RADS 4 or 5 dominant intraprostatic lesion
    Journal Article

    Gorovets, D.; Wibmer, A. G.; Moore, A.; Lobaugh, S.; Zhang, Z.; Kollmeier, M.; McBride, S.; Zelefsky, M. J.
    European Urology Oncology (2023)

    Fulltext@MSK | Save
  • Analysis of BRCA2 copy number loss and genomic instability in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Journal Article

    Barnett, E. S.; Schultz, N.; Stopsack, K. H.; Lam, E. T.; Arfe, A.; Lee, J.; Zhao, J. L.; Schonhoft, J. D.; Carbone, E. A.; Keegan, N. M.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Associations of body fat distribution and cardiometabolic risk of testicular cancer survivors after cisplatin-based chemotherapy
    Journal Article

    Wibmer, A. G.; Dinh, P. C. Jr; Travis, L. B.; Chen, C.; Bromberg, M.; Zheng, J.; Capanu, M.; Sesso, H. D.; Feldman, D. R.; Vargas, H. A.
    JNCI Cancer Spectrum (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Local extent of prostate cancer at MRI versus prostatectomy histopathology: Associations with long-term oncologic outcomes
    Journal Article

    Wibmer, A. G.; Nikolovski, I.; Chaim, J.; Lakhman, Y.; Lefkowitz, R. A.; Sala, E.; Carlsson, S. V.; Fine, S. W.; Kattan, M. W.; Hricak, H.; more...
    Radiology (2022)

    Fulltext@MSK | Save
  • Correlation between imaging-based intermediate endpoints and overall survival in men with metastatic castration-resistant prostate cancer: Analysis of 28 randomized trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients
    Journal Article

    Woo, S.; Suh, C. H.; Wibmer, A. G.; Becker, A. S.; Teo, M. Y.; Gönen, M.; Hricak, H.; Scher, H. I.; Morris, M. J.; Vargas, H. A.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Effect of pretreatment central adiposity on the cardiometabolic risk of male germ cell tumor survivors after cisplatin-based chemotherapy
    Meeting Abstract

    Wibmer, A. G.; Feldman, D. R.; Chen, C.; Bromberg, M.; Dinh, P. C.; Zheng, J.; Capanu, M.; Travis, L. B.; Vargas, H. A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study
    Journal Article

    Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save